publication date: Nov. 7, 2014

NCI to Host Small Business Innovation Research Forum


NCI is hosting a Small Business Innovation Research Investor Forum Nov. 13 at Agilent Technologies in Santa Clara, Calif., where 28 SBIR-funded companies will present cancer therapeutics, diagnostics, and devices.

The previous three NCI SBIR investor forums have resulted in the closing of approximately $300 million in investments and partnership deals to advance companies on the cutting-edge of cancer technology development.

With $119 million in funding annually, NCI SBIR is one of the largest sources of early stage funding for small businesses focused on cancer. The program has funded 18 Bridge awards for a total of $43 million in NCI funding—and venture capital firms, strategic partners, and other private investors have committed $86 million for the same projects.

More details about the forum and the presenting companies are available at

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.